Extending Patient Lifespan with LifeSTEM What is Glioblastoma? Gliomas are brain tumors that come in multiple forms ranging from low-grade, benign tumors to high-grade, malignant tumors including glioblastomas. Glioblastoma treatment involves surgical resection,...

When it comes to meeting deadlines and continuing to receive investments, the timely review of your GLP preclinical final report is very important. Timelines are generally tight, and your report is not the only study that a reviewer* is working on. So, how do you...

ECMO Vs. VAD Ventricular assist device (VAD) and extracorporeal membrane oxygenation (ECMO) are two similar temporary techniques to bridge cardiac therapy or transplants. In rare cases, they can also be a more permanent therapy for patients who are ineligible for...

Postpartum hemorrhage (PPH) remains a significant global health concern as the leading cause of maternal mortality worldwide. According to the World Health Organization (WHO), each year, about 14 million women experience PPH resulting in about 70,000 maternal deaths...

Establishing a Strong Assay Foundation Before we can conceptualize IVD product configurations, we must establish assay inputs which include, but are not limited to: Identify the need for the test, e.g. diagnose breast cancer or sepsis, identify bacteria, monitor...

Successful business partnerships within the life sciences industry are often the cornerstone of thriving drug development. Here are five essential keys to forging successful partnerships that will support your pipeline and drive innovation.1. Communication: The...

Bob BouthillierDirector, Electrical Engineering, VeranexIn this post, our director of electrical engineering Bob Bouthillier covers the importance of writing a patent for your product, and the kind of research you can do prior to and while working with a patent...

When a medical product innovator has reached the point at which preclinical research is necessary to achieve the next milestone, they have already surmounted significant obstacles. They are nearer to realizing the possibility that their product will enter the market...

All preclinical study estimates are not created equal and they can get expensive. Medical device innovators need to know what goes into the making of a high-quality, value-based preclinical study and have an understanding of the value that high-quality preclinical...